Print Page  Close Window


SEC Filings

S-1/A
OREXIGEN THERAPEUTICS, INC. filed this Form S-1/A on 04/09/2007
Entire Document
 
Table of Contents

managing member of Sofinnova Management VI, L.L.C. Dr. Powell disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
 
(4) The voting and disposition of the shares held by Scale Venture Partners II, LP is determined by a majority in interest of the six managers of Scale Venture Management II, LLC, the ultimate general partner of Scale Venture Partners II, LP. Mr. Bock is one of the managers of Scale Venture Management II, LLC and as such has a pecuniary interest in such shares, but has no voting or investment power with respect to such shares. Mr. Bock disclaims beneficial ownership of the shares held by Scale Venture Partners II, LP, except to the extent of his proportionate pecuniary interest therein.
 
(5) Includes 699,356 shares of common stock held by Montreux Equity Partners III SBIC, LP and 699,356 shares of common stock held by Montreux Equity Partners II SBIC, LP. The voting and disposition of the shares held by Montreux Equity Partners III SBIC, LP and Montreux Equity Partners II SBIC, LP are determined by Montreux Equity Management III SBIC, LLC and Montreux Equity Management II SBIC, LLC, respectively. Mr. Turner is a managing member of Montreux Equity Management III SBIC, LLC and Montreux Equity Management II SBIC, LLC. Mr. Turner disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
 
(6) The voting and disposition of the shares held by Morgenthaler Partners VII, L.P. is determined by Morgenthaler Management Partners VII, LLC, which is the managing general partner of Morgenthaler Partners VII, L.P. Robert C. Bellas, Jr., Greg E. Blonder, James W. Broderick, Daniel F. Farrar, Andrew S. Lanza, Theodore A. Laufik, Gary R. Little, John D. Lutsi, Gary J. Morgenthaler, Robert D. Pavey, G. Gary Shaffer, Alfred J.V. Stanley and Peter G. Taft are managing members of Morgenthaler Management Partners VII, LLC and share voting and investment control over the shares held by Morgenthaler Partners VII, L.P. Each managing member disclaims beneficial ownership of these shares, except to the extent of his or her pecuniary interest therein.
 
(7) Dr. Tollefson has the right to acquire these shares pursuant to outstanding options which are or will be immediately exercisable within 60 days of March 31, 2007, 250,632 of which would be subject to our right of repurchase within 60 days of March 31, 2007.
 
(8) Includes 168,120 shares Mr. McKinney has the right to acquire pursuant to outstanding options which are or will be immediately exercisable within 60 days of March 31, 2007, 61,370 of which would be subject to our right of repurchase within 60 days of March 31, 2007.
 
(9) Mr. Cooper has the right to acquire these shares pursuant to outstanding options which are immediately exercisable, 197,208 of which would be subject to our right of repurchase within 60 days of March 31, 2007.
 
(10) Effective July 11, 2006, Ms. Rollins resigned as our Chief Financial Officer.
 
(11) Includes 1,173,300 shares of common stock subject to outstanding options which are or will be immediately exercisable within 60 days of March 31, 2007, 509,210 of which would be subject to our right of repurchase within 60 days of March 31, 2007. Includes 14,583 shares acquired upon the exercise of options, none of which will be subject to our right of repurchase within 60 days of March 31, 2007.


115